台股 » 個股 » 迎廣 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

迎廣

(6117)
可現股當沖
  • 股價
    121.0
  • 漲跌
    ▲11.0
  • 漲幅
    +10.00%
  • 成交量
    36,302
  • 產業
    上市 電腦週邊類股
  • 79人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
迎廣 (6117)籌碼相關-台灣企銀-建成 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

台灣企銀-建成 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/2300.0030117.62121.00-308,851-0.34%
2024/05/20292.25193.2091.0018,1730.01%
2024/05/17290.70589.8292.00-38,099-0.04%
2024/05/16489.3000.0089.3048,2270.05%
2024/05/15289.4000.0088.3028,2420.02%
2024/05/1300.00190.1090.80-18,198-0.01%
2024/05/10689.1700.0091.0068,0460.07%
2024/05/09290.3500.0090.4027,9060.03%
2024/05/0700.00289.0585.70-27,574-0.03%
2024/05/06383.9700.0082.5037,3260.04%
2024/05/031882.8400.0081.60187,3150.25%
2024/05/02383.2300.0082.7037,3630.04%
2024/04/30182.80183.0083.2007,3820.00%
2024/04/2900.00182.0082.10-17,425-0.01%
2024/04/26182.0000.0082.7017,4930.01%
2024/04/2500.00182.9081.90-17,730-0.01%
2024/04/2200.00280.7076.10-27,917-0.03%
2024/04/1900.003081.1081.30-308,016-0.37%
2024/04/18385.3000.0084.9038,0150.04%
2024/04/16683.9000.0081.2068,1750.07%
2024/04/15492.1300.0090.1048,4510.05%
2024/04/12295.7500.0093.1028,4250.02%
2024/04/1110100.4800.0096.00108,4450.12%
2024/04/105102.5000.0098.8058,4250.06%
2024/04/0300.00485.4889.40-47,966-0.05%
2024/04/01280.2000.0079.9028,0880.02%
2024/03/29880.04480.2381.0048,3580.05%
2024/03/28278.3000.0079.9028,9010.02%
2024/03/26577.8200.0078.9059,0800.06%
2024/03/25280.5500.0080.7029,0240.02%
2024/03/21178.9000.0078.1018,9510.01%
2024/03/20280.2500.0078.0028,9500.02%
2024/03/19182.4000.0080.9018,9220.01%
2024/03/15179.7000.0079.1018,8120.01%
2024/03/14178.3000.0080.6018,7270.01%
2024/03/1300.00181.4079.60-18,661-0.01%
2024/03/1200.00184.4084.40-18,973-0.01%
2024/03/08276.7000.0075.4029,9320.02%
2024/03/07385.10782.5178.50-410,478-0.04%
2024/03/06986.39587.3085.80410,9730.04%
2024/03/05182.50183.0083.00010,4460.00%
2024/02/2300.00181.7076.40-111,314-0.01%
2024/02/2200.00179.6077.10-111,286-0.01%
2024/02/21179.0000.0079.10111,3360.01%
2024/02/19179.9000.0077.50111,4020.01%
2024/02/0100.00572.5072.10-512,435-0.04%
2024/01/1900.00282.2077.70-215,258-0.01%
2024/01/16178.7000.0077.50115,5250.01%
2024/01/10276.50377.5077.50-114,964-0.01%
2024/01/09178.002578.3378.80-2414,799-0.16%
2024/01/0500.00277.7077.70-214,363-0.01%
2024/01/04182.50282.8079.00-114,269-0.01%
2024/01/0300.00281.5079.80-213,760-0.01%
2023/12/26179.10278.3077.20-113,738-0.01%
2023/12/25183.0000.0077.50113,7510.01%
2023/12/21271.9000.0071.10212,9850.02%
2023/12/20272.9000.0072.90212,9980.02%
2023/12/18473.6500.0073.80413,0050.03%
2023/12/15575.4000.0072.50513,0240.04%
2023/12/141877.9500.0076.501813,0260.14%
2023/12/13177.3000.0076.00113,0240.01%
2023/12/12977.7000.0077.70913,0360.07%
2023/12/08277.4000.0075.20213,0240.02%
2023/12/074280.594278.5177.30013,0940.00%
2023/12/06177.0000.0077.00112,3910.01%
2023/12/05573.30574.0075.90011,6900.00%
2023/12/042067.332168.9569.00-111,320-0.01%
2023/11/3000.00161.9061.90-19,899-0.01%
2023/11/2900.00356.2056.30-39,627-0.03%
2023/11/28151.0000.0051.2019,3580.01%
2023/11/24153.3000.0052.4019,2620.01%
2023/11/23154.00757.3753.50-68,975-0.07%
2023/11/22252.5000.0052.2028,5720.02%
2023/11/15253.25152.2052.2019,2090.01%
2023/11/10251.30252.4551.6008,5400.00%
2023/11/08154.3000.0052.1018,0900.01%
2023/11/01543.0000.0043.3056,4500.08%
2023/10/301056.451054.1049.8005,9170.00%
2023/10/2700.00155.0055.30-15,229-0.02%
2023/10/19144.4500.0045.9514,6610.02%
2023/10/03242.00243.2543.3004,5380.00%
2023/08/2200.00134.5534.55-12,736-0.04%
2023/08/1800.00127.8528.60-12,425-0.04%
2023/07/31128.40129.4526.8001,8950.00%
2023/07/28129.1000.0028.3511,8110.06%
2023/07/2700.00129.2030.45-11,672-0.06%
2023/07/26127.8500.0027.7011,5830.06%
2023/07/0600.001025.0525.05-10731-1.37%
2023/07/042019.431020.1020.75104372.29%
2022/08/24322.45321.7021.2005120.00%
2020/02/0400.00214.4014.50-214-13.45%
2020/01/30213.7000.0013.8021413.47%
『本益成長比 』 評估成長股 新復興、 聯亞、迎廣 漲勢不回頭?Anue鉅亨-2024/03/18
〈焦點股〉迎廣1月營收2.56億創近10年新高 亮燈漲停Anue鉅亨-2024/02/16
【新台股龍捲風】看NVIDIA不如看NBI生技,松瑞藥3天逼近3根漲停 迎廣飆漲VS材料大跌,驚天動地33持續!Anue鉅亨-2023/12/05
迎廣 相關文章
迎廣 相關影音